VIE/DRW3 (VIE/DRW3)

Vienna Stock Exchange: VIE/DRW3 · EUR

€105

-0.20 (-0.2%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	3.6B
Net income (ttm)	169.6M
EPS (ttm)	€9.06
P/E (trailing)	11.5x
P/E (forward)	10.9x
Dividend	€2.27 (2.17%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.6B
Net income (ttm): 169.6M
EPS (ttm): €9.06
P/E (trailing): 11.5x
P/E (forward): 10.9x
Market cap: 1.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E10.9

P25 n/aP50 n/aP75 n/a

Trailing P/E11.5

P25 n/aP50 n/aP75 n/a

ROE10.5

P25 n/aP50 n/aP75 n/a

ROIC9.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/DRW3 indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

EUR

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-10-29
Employees	16,009
Employees change	128
Employees growth	0.77%
Enterprise value	EUR 1.7B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-09-30
First seen	2026-10-10
Fiscal year end	December
Founded	1889
Industry	Medical Devices
Is primary listing	No
ISIN number	DE0005550636
Last earnings date	2026-10-29
Last refreshed	2026-10-30
Market cap	EUR 1.7B
Next earnings date	2027-03-17
Price	EUR 104.60
Price currency	EUR
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-29
Symbol	vie/DRW3
Website	https://www.draeger.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	16.38x
Average P/E ratio (3Y)	8.86x
Average P/E ratio (5Y)	11.1x
Earnings yield	8.66%
EV/Earnings	9.75x
EV/EBIT	6.48x
EV/EBITDA	4.25x
EV/FCF	7.27x
EV/Sales	0.46x
FCF / EV yield	13.75%
FCF yield	13.41%
Forward P/E	10.95x
Graham number	157.67018
Graham upside	50.74%
Lynch fair value	EUR 52.33
Lynch upside	-49.97%
P/B ratio	0.99x
P/E ratio	11.55x
P/FCF ratio	7.45x
P/OCF ratio	5.29x
P/S ratio	0.47x
Price / tangible book value	1.23x
Price/EBITDA ratio	4.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	7.08%
EBITDA margin	9.46%
Effective tax rate	33.38%
FCF margin	6.33%
Gross margin	46.39%
Operating margin	7.08%
Pretax margin	7.05%
Profit margin	4.72%
Profit per employee	EUR 10,594
Profitable quarters	5
Profitable years	3
Revenue per employee	EUR 224,394
ROA	5.05%
ROA (5Y)	2.89%
ROCE	10.94%
ROE	10.48%
ROE (5Y)	6.81%
ROIC	9.63%
ROIC (5Y)	7.24%
Tax / revenue	2.35%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	40.69%
EPS growth (QoQ)	14.41%
EPS growth quarters	4
EPS growth years	3
FCF growth	66.55%
FCF growth (Q)	66.22%
FCF growth 3Y	26.04%
FCF growth 5Y	-15.24%
Gross profit growth	7.47%
Gross profit growth (Q)	6.22%
Gross profit growth 3Y	5.01%
Gross profit growth 5Y	-0.22%
Net income growth	40.3%
Net income growth (Q)	-4.72%
Net income growth (QoQ)	15.18%
Net income growth 3Y	21.86%
Net income growth 5Y	-5.42%
Net income growth quarters	4
Net income growth years	3
OCF growth	58.13%
OCF growth (Q)	53.01%
OCF growth 10Y	8.8%
OCF growth 3Y	20.87%
OCF growth 5Y	-12.72%
Operating income growth	57.27%
Operating income growth (Q)	-13.69%
Operating income growth 3Y	24.63%
Operating income growth 5Y	-9.84%
Revenue growth	5.06%
Revenue growth (Q)	2.1%
Revenue growth (QoQ)	0.41%
Revenue growth 10Y	3.57%
Revenue growth 3Y	2.47%
Revenue growth 5Y	0.42%
Revenue growth quarters	4
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -93.2M
Depreciation and amortization	EUR 85.4M
EBIT	EUR 254.5M
EBITDA	EUR 340M
EPS	EUR 9.06
Financing cash flow	EUR -162.1M
Free cash flow	EUR 227.4M
Gross profit	EUR 1.7B
Income taxes	EUR 84.5M
Investing cash flow	EUR -82.5M
Net borrowing	EUR -96.9M
Net cash flow	EUR 82.6M
Net income	EUR 169.6M
Operating income	EUR 254.5M
Revenue	EUR 3.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 90.54
Debt / EBITDA	0.59
Debt / equity	0.13
Debt / FCF	1.01
Interest coverage	12.85
Long-term assets	EUR 1.3B
Long-term liabilities	EUR 615.7M
Net cash (debt)	EUR 42M
Net cash / market cap	2.48%
Net debt / EBITDA	-0.12
Net debt / equity	-0.02
Net debt / FCF	-0.18
Piotroski F-Score	7
Property, plant and equipment	EUR 590.5M
Shareholders' equity	EUR 1.7B
Tangible book value	EUR 1.4B
Tangible book value per share	EUR 73.00
Total assets	EUR 3.3B
Total cash	EUR 270.9M
Total debt	EUR 228.9M
Total liabilities	EUR 1.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.14
Current assets	EUR 1.9B
Current liabilities	EUR 936.6M
Current ratio	2.07
Inventory turnover	2.58
Net working capital	EUR 739.9M
Quick ratio	1.13
Working capital	EUR 1B
Working capital turnover	4.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.28%
Dividend growth	11.82%
Dividend growth (3Y)	128.61%
Dividend growth (5Y)	42.97%
Dividend growth years	2
Dividend payment date	2026-05-13
Dividend payment years	9
Dividend payout frequency	Annual
Dividend per share	EUR 2.27
Dividend yield	2.17%
Ex-dividend date	2026-05-11
Last dividend	EUR 2.27
Payout ratio	24.75%
Shareholder yield	2.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 98.82
1D price change	-0.19%
1M price change	-15.78%
1M total return	-15.78%
1W price change	6.3%
1W total return	6.3%
1Y price change	38%
1Y return CAGR	41.59%
1Y total return	41.55%
20-day SMA	EUR 107.58
200-day SMA	EUR 96.30
3M price change	8.73%
3M total return	8.73%
3Y price change	121.85%
3Y return CAGR	34.6%
3Y total return	143.93%
50-day SMA	EUR 111.60
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 125.20
52-week high date	2026-09-29
52-week low	EUR 66.70
52-week low date	2025-12-11
5Y price change	50.4%
5Y return CAGR	10.76%
5Y total return	66.67%
6M price change	13.7%
6M total return	16.63%
All-time high	EUR 125.20
All-time high date	2026-09-29
All-time low	EUR 38.48
All-time low date	2019-08-16
Average true range (ATR)	EUR 2.80
Average volume	6.9
Change from 52-week high	-16.45%
Change from 52-week low	56.82%
Change from all-time high	-16.45%
Change from all-time low	171.83%
Change from open	-0.19%
Day's gap	0%
High price	EUR 104.80
Low price	EUR 104.60
Monthly RSI	64.79
Open price	EUR 104.80
Position in 52-week range	0%
Previous close	EUR 104.80
Price vs 150-day SMA	5.85%
Price vs 20-day SMA	-2.77%
Price vs 200-day SMA	8.62%
Price vs 50-day SMA	-6.28%
Relative volume	6.52
RSI	45.24
Sharpe ratio	1.2
Sharpe ratio (3Y)	0.9
Sharpe ratio (5Y)	0.36
Sortino ratio	2.09
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	0.73
Weekly RSI	53.09
YTD price change	51.59%
YTD total return	55.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	11.5M
Shares change (QoQ)	0.67%
Shares change (YoY)	-0.28%
Shares held by insiders	37.19%
Shares held by institutions	17.3%

Deeper analysis on VIE/DRW3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/DRW3 report

Is a complete VIE/DRW3 research report available?

No complete published report is available for vie/DRW3 (VIE/DRW3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/DRW3 (VIE/DRW3)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/DRW3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/DRW3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/DRW3

Frequently asked questions